Posted on 02.07.22
The promise of Azlocillin and Cefotaxime for Lyme Disease
Lyme disease, caused by Borrelia burgdorferi, is one
of most common vector-borne diseases. It
is estimated that over 470,000 people are diagnosed and treated for the disease
each year in the United States, based on insurance claims data...
